Tetsuhide Ito

Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts.

J. Furuse, S. Hijioka, Taku Aoki, 2023, Investigational New Drugs.

Everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET): Impact of somatostatin analog use on progression-free survival in the RADIANT-3 trial.

E. Van Cutsem, T. Hobday, C. Lombard-Bohas, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.